直接选择性激光小梁成形术治疗开角型青光眼研究设计:多中心随机对照研究者设盲试验(GLAUrious)
GLAUrious试验为多中心随机对照研究者设盲研究,旨在检验经角膜缘直接选择性激光小梁成形术(DSLT)在降低开角型青光眼(OAG)眼压方面不劣于选择性激光小梁成形术(SLT)的假设。主要疗效指标为6个月时眼压较基线变化的组间差异,样本量164例可检测1.95 mmHg的非劣效界值。
要点
- DSLT采用120个脉冲、3纳秒、400微米光斑、能量1.4-1.8毫焦,2秒内经角膜缘传递。
- SLT采用约100个脉冲、3纳秒、400微米光斑,360度经角膜缘使用任何前房角镜,能量0.3-2.6毫焦。
- 纳入年龄≥40岁OAG(含剥脱或色素性青光眼)或高眼压症,未治疗或洗脱后眼压22-35 mmHg。
核心结论
- 试验假设经角膜缘DSLT在降低OAG眼压方面有效且不劣于SLT。
研究设计与样本
- 多中心、随机、对照、研究者设盲试验,样本量164例。
主要发现
- 主要疗效结局为6个月时眼压较基线变化的组间差异。
- 次要结局包括3、6、12个月眼压平均百分比降低、6个月时眼压较基线降低至少20%的参与者比例、12个月降眼压药物变化及安全性评估。
关键数值与推荐
- 样本量164例可检测眼压较基线变化的非劣效界值1.95 mmHg。
- DSLT参数:120个脉冲、3纳秒、400微米光斑、能量1.4-1.8毫焦,2秒内经角膜缘传递。
- SLT参数:约100个脉冲、3纳秒、400微米光斑,360度经角膜缘使用任何前房角镜,能量0.3-2.6毫焦。
- 入选标准:年龄≥40岁,OAG(包括剥脱性或色素性青光眼)或高眼压症,未治疗或洗脱后眼压22-35 mmHg。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Laser trabeculoplasty is an effective and widely used treatment for glaucoma. A new laser technology, the Eagle direct selective laser trabeculoplasty (DSLT) device, may provide automated, fast, simple, safe and effective laser treatment for glaucoma in a broader range of clinical settings. This trial aims to test the hypothesis that translimbal DSLT is effective and not inferior to selective laser trabeculoplasty (SLT) in reducing intraocular pressure (IOP) in open angle glaucoma (OAG). METHODS AND ANALYSIS: This is a multicentre, randomised, controlled, investigator-masked study. The primary efficacy outcome is intergroup difference in mean change from baseline IOP measured at 6 months. Secondary outcomes include mean percentage reduction in IOP at 3, 6 and 12 months; proportion of participants with at least 20% reduction in IOP from baseline at 6 months; change in ocular hypotensive medications at 12 months and evaluation of safety. Participants were aged >= 40 years with OAG, including exfoliative or pigmentary glaucoma, or ocular hypertension with untreated or washed out IOP 22-35 mm Hg. TREATMENTS: DSLT: 120 shots, 3 ns, 400 µm spot size, energy 1.4-1.8 mJ delivered at the limbus over 2 s. SLT: approximately 100 shots, 3 ns, 400 µm spot size administered 360 degrees at the limbus using any gonioscopy lens, energy 0.3-2.6 mJ. A sample size of 164 is sufficient to detect a non-inferiority margin of 1.95 mm Hg for change from baseline IOP. CLINICAL TRIAL REGISTRATION NUMBER: NCT03750201, ISRCTN14033075.
引用
- Congdon N, Azuara-Blanco A, Solberg Y, et al. Direct selective laser trabeculoplasty in open angle glaucoma study design: a multicentre, randomised, controlled, investigator-masked trial (GLAUrious). Br J Ophthalmol. 2021. PMID: 34433548. doi:10.1136/bjophthalmol-2021-319379
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。